Compare BYSI & ORIQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BYSI | ORIQ |
|---|---|---|
| Founded | 2010 | 2024 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.0M | 87.6M |
| IPO Year | 2017 | 2025 |
| Metric | BYSI | ORIQ |
|---|---|---|
| Price | $1.97 | $10.16 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 23.1K | 6.4K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.98 | $9.98 |
| 52 Week High | $3.44 | $10.20 |
| Indicator | BYSI | ORIQ |
|---|---|---|
| Relative Strength Index (RSI) | 49.57 | N/A |
| Support Level | $1.83 | N/A |
| Resistance Level | $2.21 | N/A |
| Average True Range (ATR) | 0.20 | 0.00 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 50.58 | 0.00 |
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.
Origin Investment Corp I is a blank check company.